Aurora Cannabis (TSE:ACB) has released an update.
Aurora Cannabis, a leading global medical cannabis company, has announced an upcoming investor conference call on June 20, 2024, to discuss its fourth quarter and fiscal year 2024 results. The results will be revealed prior to market opening, with CEO Miguel Martin and CFO Simona King leading the call. The company continues to innovate in the medical and recreational cannabis sectors with a diverse portfolio of brands.
For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.
